MEREDITH CHIDSEY: Open Payments
NPI 1952730160 · QUINCY, MA. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$2,296 in 92 payments from 22 companies in 2025. Trend: 2023 $73 · 2024 $728 · 2025 $2,296
Food & beverage: $2,036Education: $260
| Company | Payments | Amount |
|---|---|---|
| Janssen Biotech, Inc. | 9 | $396 |
| ABBVIE INC. | 17 | $385 |
| SUN PHARMACEUTICAL INDUSTRIES INC. | 8 | $218 |
| Incyte Corporation | 8 | $195 |
| Regeneron Healthcare Solutions, Inc. | 7 | $156 |
| LEO Pharma Inc. | 5 | $132 |
| Novartis Pharmaceuticals Corporation | 5 | $109 |
| Organon LLC | 3 | $90 |
| E.R. Squibb & Sons, L.L.C. | 4 | $89 |
| SANOFI-AVENTIS U.S. LLC | 1 | $80 |
Products named: TREMFYA, DUPIXENT, SKYRIZI, OPZELURA, RINVOQ, ADBRY, ILUMYA, Sotyktu.
Industry payments across MA — which companies pay providers there.
